Opgen Overview
Latest ROE for Opgen: 83.85% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow83.85%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
As of the most recent data, OPGN shows a ROE of 83.85%. That is above the Healthcare sector average of 20.86%. Scroll down for historical charts and peer comparison views.
The Healthcare sector average ROE is about 20.86%. Opgen is at 83.85%, which is higher that average. That is roughly 302.0% above the sector mean. Use the comparison chart on this page to see how OPGN stacks up against individual peers as well.
Check the historical chart to see whether OPGN's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Opgen with peers to see if the move is company-specific or sector-wide.
Besides this return on equity page, Stockcircle has Opgen's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 83.85%) with ownership activity and broader fundamentals.
The Healthcare average ROE is about 20.86%, while OPGN is at 83.85%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
